INCYTE CORPORATION Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year
INCYTE CORPORATION (INCY) had Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year of -$700.00 thousand as of 2019-12-31, per its 10-K filed 2020-02-13.
Discontinued › Notes › Compensation Related Costs › Defined Benefit Plan › Defined Benefit Plan, Expected Amortization, Next Fiscal Year
us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear · last filed 2020-02-13
- 2019-12-31: Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year -$700.00K.
- 2018-12-31: Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year $300.00K.
| Period end | Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year |
|---|---|
| 2019-12-31 | -$700.00K 10-K · filed 2020-02-13 |
| 2018-12-31 | $300.00K 10-K · filed 2019-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |